Okamoto Industries (5122) Q2 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 earnings summary
12 Nov, 2026Executive summary
H1 FY2027 net sales rose 9.7% YoY to ¥58,050 million; operating income increased 72.4% to ¥4,315 million and parent-attributable profit rose 83.5% to ¥3,567 million.
Profit growth reflected higher sales from proactive order acquisition, yen depreciation, price revisions and stabilization of antimony prices.
Financial highlights
Gross profit increased to ¥12,251 million from ¥10,144 million; SG&A rose to ¥7,936 million from ¥7,640 million.
Ordinary income rose 58.1% YoY to ¥5,349 million; net income was ¥3,571 million, versus ¥1,957 million in the prior-year period.
Comprehensive income was ¥4,487 million, down 32.2% YoY from ¥6,620 million.
Outlook and guidance
FY2027 forecast: net sales ¥115,000 million (+6.4%), operating income ¥6,700 million (+7.2%), ordinary income ¥8,700 million (+1.2%) and parent-attributable profit ¥5,700 million (+17.4%).
Full-year EPS forecast is ¥334.19; the latest consolidated earnings forecast was unchanged.
Forecasts rely on currently available information and assumptions; actual results may differ for various reasons.
Latest events from Okamoto Industries
- Profits and sales surged year-over-year, prompting upward revisions to earnings and dividends.5122
Q1 2027 - Net sales grew 6.9% year-over-year, with full acquisition of RIKEN CORUNDUM completed.5122
Q2 2025 - Sales and operating profit rose, but net profit fell on higher impairment losses.5122
Q1 2025 - Sales rose but profits fell due to higher costs and impairments, with lower segment margins.5122
Q3 2025 - Net sales rose 2.8% year-over-year, but profit and operating income declined amid flat FY2026 outlook.5122
Q4 2025 - Net sales rose, but profits declined sharply year-over-year; guidance and dividends unchanged.5122
Q1 2026 - Profits fell sharply on weaker demand and higher costs, but dividends and buybacks continue.5122
Q2 2026 - Profits fell on currency and cost pressures, but full-year guidance remains optimistic.5122
Q3 2026 - Sales and profits fell sharply, with only modest recovery forecast amid ongoing risks.5122
Q4 2026